MedPath

Fomepizole

Fomepizole Injection, 1.5 g/1.5 mL (1 g/mL) Sterile Rx only

Approved
Approval ID

7e133194-dacb-446a-a657-2d2430a02373

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 7, 2023

Manufacturers
FDA

Gland Pharma Limited

DUNS: 918601238

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fomepizole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68083-510
Application NumberANDA216791
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fomepizole
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 10, 2023
FDA Product Classification

INGREDIENTS (1)

FOMEPIZOLEActive
Quantity: 1 g in 1 mL
Code: 83LCM6L2BY
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fomepizole - FDA Drug Approval Details